ArticleOncotarget2017

Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.

Cheng-Lung Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.